Medindia

X

GSK to Pay $90 Million as Settlement for Misrepresenting Avandia Claims

by Kathy Jones on  November 16, 2012 at 6:09 PM Drug News   - G J E 4
GlaxoSmithKline has agreed to pay more than $90 million to 38 states as part of settling the claims that the company deliberately misrepresented the health risks associated with diabetes drug Avandia.
 GSK to Pay $90 Million as Settlement for Misrepresenting Avandia Claims
GSK to Pay $90 Million as Settlement for Misrepresenting Avandia Claims
Advertisement

A Senate Committee report had earlier found that Avandia increased the risk of cardiovascular disease in diabetic patients and GSK had known about the health risks but had decided not to reveal it.

Advertisement
The company had been accused of indulging in illegal means to promote the drug and has so far paid more than $3 billion in order to settle federal charges and consumer lawsuits.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All